Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...

Sovereign Pharma, part of Dadachanji Group of Companies and a leader in high-quality injectable manufacturing, received its European Union approval for aseptic and terminally sterilized products ...

Announcements included mergers & acquisitions, capital expansions for manufacturing and development capacity across the bio/pharmaceutical value chain ... and constructing a dedicated commercial-scale ...

Process & Analytical Development GMP Drug Substance & Product Manufacturing GMP Aseptic Fill & Finish Quality Control Release Testing & Stability Studies Workforce Development & Training Visit ...

ft., clinical- and commercial-facility in Princeton, NJ – now operational for development programs and GMP services available in Q2 2025. The facility includes an immediate $12M capital investment in ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

Governments and employers worldwide have expanded access to care. Yet pharmaceutical innovation hasn’t kept pace. Since the blockbuster success of drugs such as Prozac and Zoloft in the 1990s ...

White Raven, a newly established CDMO specializing in GMP formulation and aseptic fill & finish services for clinical and orphan drugs, has obtained Good Manufacturing Practice (GMP) certification, ...